Effects of Core Strengthening and PNF Pattern on Balance and Plantar Pressure in Chronic Stroke (PNF)

Effects of Core Strengthening and Proprioceptive Neuromuscular Facilitation Pattern on Static Standing Balance and Plantar Pressure in Chronic Stroke

To compare the effects of core strengthening and PNF on standing balance and plantar pressure in chronic stroke patients

Study Overview

• Status: Recruiting
• Conditions: Stroke; Paralysis
• Intervention / Treatment: Other: Routine physical therapy; Other: core strengthening exercises

Detailed Description

The effects of different exercise regimes and PNF techniques on balance and plantar pressure had been studied. This study focuses on determining the effects of CSE and PNF techniques on developing static standing balance and plantar pressure in stroke patients using PoData

• Study Type: Interventional
• Enrollment (Anticipated): 73
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Sameed Liaqat, DPT; Phone Number: 0324 9004200; Email: samiliaqat3@gmail.com

Study Locations

• Pakistan
  • Punjqb
    • Lahore, Punjqb, Pakistan, 40050
      • Recruiting
      • The University of Lahore Teaching Hospital
      • Contact: Wardah Rauf, MSPTN; Phone Number: 03374915954; Email: wardahrauf99@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 45 years to 60 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• • Age 45-60

  • Score of 9 or higher on the static component of Berg Balance Scale
  • Both genders will be recruited.
  • First ever episode of stroke
  • Duration of stroke greater than 6 months.
  • Having a score of equal to or less than 2 on the Modified Ashworth Scale
  • Having a score of greater than or equal to 24 on the Mini-mental state examination in order to understand the commands.

Exclusion Criteria:

• • Concurrent orthopedic (for e.g. amputation ) that may hamper standing

  • Relevant psychiatric disorders that may prevent from following instructions.
  • Other medical drugs that may influence our intervention
  • Condition contraindicating physical activity
  • Use of cardiac pacemakers.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Group A; • Group A (control group) will receive routine physical therapy involving muscle strengthening exercises, range of motion exercises, and stretching exercises up to the patient's tolerance. Other exercises will be pelvic bridging, rolling, sitting and standing exercises, walking practice and balancing in parallel bars, and wobble board exercises. Each session will be of 60 minutes 5 times weekly for 6 weeks	Other: Routine physical therapy; •Group A (control group) will receive routine physical therapy involving muscle strengthening exercises, range of motion exercises, and stretching exercises up to the patient's tolerance. Other exercises were pelvic bridging, rolling, sitting and standing exercises, walking practice and balancing in parallel bars, and wobble board exercises. Each session was of 60 minutes 5 times weekly for 6 weeks
Experimental: Group B; Group B (experimental group) will receive routine physical therapy for 20 minutes and additionally PNF technique (rhythmic initiation, and then agonistic reversals will be performed in lower extremity in D1 flexion pattern and D1 extension pattern up to patient's tolerance and core strengthening for 20 minutes 5 times weekly for 6 weeks. The outcome measure will be measured at and 6th week interval	Other: core strengthening exercises; •Group B (experimental group) received routine physical therapy for 20 minutes and additionally PNF technique (rhythmic initiation, and then agonistic reversals were performed in the lower extremity in D1 flexion pattern and D1 extension pattern up to the patient's tolerance and core strengthening for 20 minutes 5 times weekly for 6 weeks. The outcome measure was measured at baseline and 6th-week interval

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Static Standing balance	It is measured using static component of berg balance scale. The items are scored from 0 to 4, with a score of 0 representing an inability to complete the task and a score of 4 representing independent item completion. Static component score is calculated out of 24 possible points. Scores of 0 to 9 represent static balance impairment, 10 to 15 represent acceptable static balance, and 15 to 24 represent good static balance	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Plantar pressure	PoData (Chinesport, Italy Version 5.0) this system provides information about weight distribution by measuring total body weight on fifth, first metatarsal and heel For a healthy individual the normal distribution is as follows 16.67% of the total body weight on the fifth metatarsal head, 33.33% of the total body weight on first metatarsal. 50% of the total body weight on heel	6 months

Collaborators and Investigators

• Sponsor: University of Lahore
• Investigators: Principal Investigator: Sameed Liaqat, DPT, The University of Lahore

Study record dates

Study Major Dates

• Study Start (Actual): December 3, 2021
• Primary Completion (Anticipated): June 30, 2022
• Study Completion (Anticipated): August 14, 2022

Study Registration Dates

• First Submitted: June 23, 2022
• First Submitted That Met QC Criteria: June 23, 2022
• First Posted (Actual): June 29, 2022

Study Record Updates

• Last Update Posted (Actual): June 29, 2022
• Last Update Submitted That Met QC Criteria: June 23, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Keywords: Stroke, Static Balance, PNF, Plantar Pressure, PoData
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Stroke; Paralysis
• Other Study ID Numbers: IRB-UOL-FAHS/1089/2021

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No